Comparison of two immunoassays for the measurement of serum HE4 for ovarian cancer
Introduction: The use of Human Epididymis Protein 4 (HE4) as a biomarker for ovarian cancer is gaining traction, providing the impetus for development of a high throughput automated HE4 assay that is comparable to the conventional manual enzyme immunometric-assay (EIA). The aim of this study was to...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier B.V.
2021
|
Subjects: | |
Online Access: | View Fulltext in Publisher |